Quantcast

Latest Transplantation medicine Stories

2014-07-31 12:08:01

Dana-Farber Cancer Institute Study in NEJM reviews 10 years of data, argues for expansion of newborn screening Children born with so-called "bubble boy" disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. These findings, the researchers say, argue for expanding newborn...

2014-07-28 13:28:02

University of Oxford Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation. The key results are reported in The Lancet and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: the powerful combinations of...

2014-07-28 12:27:34

TOTOWA, N.J., July 28, 2014 /PRNewswire/ -- BiologicTx(®) announced their Discovery 2 Life((TM)) (D2L((TM))), a leading digital health platform designed to guide and support hospitals, clinicians and patients throughout the organ transplant continuum. D2L supports aspects of the organ transplant process, including organization of data associated with enrolling a transplant candidate into a desensitization therapeutic program, donor data management (including identifying optimal...

2014-07-28 04:21:40

HORSHOLM, Denmark, July 28, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus(®) for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union (EU). Key points:

2014-07-24 12:25:16

CARLSBAD, Calif., July 24, 2014 /PRNewswire/ -- Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts within The Bone and Joint Journal. Initially presented at the European Orthopaedic Research Society meeting, both abstracts further substantiate the differentiation and clinical benefit of OsteoAMP® allograft-derived growth factor. The first abstract, "Osteoinductivity and osteogenicity of...

2014-07-21 16:26:54

New Study Published in Aesthetic Surgery Journal SAN DIEGO, July 21, 2014 /PRNewswire/ -- Puregraft LLC, a leader in the development and commercialization of autologous fat (adipose) grafting systems, is pleased to announce that a peer-reviewed paper evaluating the use of the Puregraft adipose filtration technology has been published in the July 2014 issue of Aesthetic Surgery Journal(1). In this study, the investigators compared the rates of graft retention (an important measure...

2014-07-18 16:20:57

Gase's racecar will feature Dylan Richardson, a seven-year-old donor who saved three lives through donation CENTENNIAL, Colo., July 18, 2014 /PRNewswire-USNewswire/ --AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, is sponsoring Joey Gase, a NASCAR Nationwide Series Driver and donor son, in the NASCAR Nationwide Series EnjoyIllinois.com 300 race at...

2014-07-13 23:02:44

ReportsnReports.com adds “EpiCast Report Graft-Versus-Host Disease - Epidemiology Forecast to 2023” to its store. US will have the highest number of diagnosed incident cases of aGVHD in the 6MM, with 4,989 diagnosed incident cases. Dallas, Texas (PRWEB) July 13, 2014 Epidemiologists forecast an increase in the diagnosed incident cases of aGVHD in the 6MM, from 8,062 diagnosed incident cases in 2013 to 11,568 diagnosed incident cases in 2023, at an Annual Growth Rate (AGR) of 4.35%,...

2014-07-11 23:05:30

Anterior Cruciate Ligament (ACL) reconstructions occur more than 200,000 times a year, but the type of material used to create a new ligament may determine how long you stay in the game, say researchers presenting their work today at the Annual Meeting of the American Orthopaedic Society of Sports Medicine (AOSSM). Seattle, WA (PRWEB) July 11, 2014 Anterior Cruciate Ligament (ACL) reconstructions occur more than 200,000 times a year, but the type of material used to create a new ligament...

2014-07-08 08:31:51

GRENOBLE, France, July 8, 2014 /PRNewswire/ -- ImmunID announced today that Dr Miguel Perales, Deputy Chief, Adult Bone Marrow Transplant Service and Director, Adult Stem Cell Transplant Fellowship at Memorial Sloan Kettering Cancer Center in New York, is joining its Scientific Advisory Board. http://photos.prnewswire.com/prnvar/20140707/124850 Dr Perales' clinical practice focuses on allogeneic and autologous stem cell transplantation for hematological malignancies as well as novel...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related